These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31419569)

  • 21. Enhancing Administrative Claims Data: Feasibility, Validation and Application of Linking Medicare Claims Data and National Marrow Donor Program Search Data.
    Preussler JM; Meyer CL; Sees Coles JA; Yoo D; Mau LW; Garrett ND; Auletta JJ
    JCO Clin Cancer Inform; 2022 Oct; 6():e2200069. PubMed ID: 36228178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report.
    Passweg JR; Baldomero H; Bader P; Basak GW; Bonini C; Duarte R; Dufour C; Kröger N; Kuball J; Lankester A; Montoto S; Nagler A; Snowden JA; Styczynski J; Mohty M;
    Bone Marrow Transplant; 2018 Sep; 53(9):1139-1148. PubMed ID: 29540849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial.
    Dehn JG; Logan B; Shaw BE; Devine S; Ciurea SO; Horowitz M; He N; Pusic I; Srour SA; Arai S; Juckett M; Uberti J; Hill L; Vasu S; Hogan WJ; Hayes-Lattin B; Westervelt P; Bashey A; Farhadfar N; Grunwald MR; Leifer E; Symons H; Saad A; Vogel J; Erickson C; Buck K; Lee SJ; Pidala J
    medRxiv; 2024 Sep; ():. PubMed ID: 39371123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Providing Level-of-Match Information to Perfectly Matched Unrelated Stem Cell Donors: Evaluating Acceptability and Potential Changes in Donor Availability.
    Switzer GE; Macis M; Fabi R; Abress L; Confer D; Bruce J; Howe K; Fowler S; McNulty M; Pastorek G; Dew MA
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):2110-2118. PubMed ID: 29574124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors.
    Anasetti C; Hansen JA
    Transfus Sci; 1994 Sep; 15(3):221-30. PubMed ID: 10155543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The National Marrow Donor Program.
    Stroncek D; Bartsch G; Perkins HA; Randall BL; Hansen JA; McCullough J
    Transfusion; 1993 Jul; 33(7):567-77. PubMed ID: 8333020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unrelated donor stem cell transplant: donor selection and search process.
    Karanes C
    Pediatr Transplant; 2003; 7 Suppl 3():59-64. PubMed ID: 12603695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of strategic alternative donor selection or suspending donor search based on Japan Marrow Donor Program coordination status.
    Kawashima N; Nishiwaki S; Shimizu N; Kamoshita S; Watakabe K; Yokohata E; Kurahashi S; Ozawa Y; Miyamura K
    Int J Hematol; 2018 May; 107(5):551-558. PubMed ID: 29374827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Return to school practices after hematopoietic cell transplantation: a survey of transplant centers in the United States.
    Bhatt NS; Meyer CL; Mau LW; Auletta JJ; Baker KS; Broglie L; Carpenter PA; Choi SW; Dandoy CE; Devine S; Phelan R
    Bone Marrow Transplant; 2024 May; 59(5):653-659. PubMed ID: 38378916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HapLogic: A Predictive Human Leukocyte Antigen-Matching Algorithm to Enhance Rapid Identification of the Optimal Unrelated Hematopoietic Stem Cell Sources for Transplantation.
    Dehn J; Setterholm M; Buck K; Kempenich J; Beduhn B; Gragert L; Madbouly A; Fingerson S; Maiers M
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2038-2046. PubMed ID: 27496216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?
    Nishiwaki S; Atsuta Y; Tanaka J
    Bone Marrow Transplant; 2013 Nov; 48(11):1369-76. PubMed ID: 23474804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS Initiative.
    Auletta JJ; Khera N; DeMartino P; Kelkar AH; Yusuf RA; Davies SM; Knutson J; Beaver E; Maloney A; Majhail NS
    Transplant Cell Ther; 2023 Nov; 29(11):713-720. PubMed ID: 37579920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
    Atsuta Y; Baldomero H; Neumann D; Sureda A; DeVos JD; Iida M; Karduss A; Purtill D; Elhaddad AM; Bazuaye NG; Bonfim C; De la Camara R; Chaudhri NA; Ciceri F; Correa C; Frutos C; Galeano S; Garderet L; Gonzalez-Ramella O; Greco R; Hamad N; Hazenberg MD; Horowitz MM; Kalwak K; Ko BS; Kodera Y; Koh MB; Liu K; McLornan DP; Moon JH; Neven B; Okamoto S; Pasquini MC; Passweg JR; Paulson K; Rondelli D; Ruggeri A; Seber A; Snowden JA; Srivastava A; Szer J; Weisdorf D; Worel N; Greinix H; Saber W; Aljurf M; Niederwieser D
    Haematologica; 2024 Oct; 109(10):3282-3294. PubMed ID: 38721749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program.
    MacMillan ML; Davies SM; Nelson GO; Chitphakdithai P; Confer DL; King RJ; Kernan NA
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):16-22. PubMed ID: 18721776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
    Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
    Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method.
    Dubois V; Detrait M; Sobh M; Morisset S; Labussière H; Giannoli C; Nicolini F; Moskovtchenko P; Mialou V; Ducastelle S; Rey S; Thomas X; Barraco F; Tedone N; Marry E; Garnier F; Bertrand Y; Michallet M
    Hum Immunol; 2016 Nov; 77(11):1008-1015. PubMed ID: 26902994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efforts of the United States' National Marrow Donor Program and Registry to improve utilization and representation of minority donors.
    Johansen KA; Schneider JF; McCaffree MA; Woods GL;
    Transfus Med; 2008 Aug; 18(4):250-9. PubMed ID: 18783584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups.
    Murata M; Takenaka K; Uchida N; Ozawa Y; Ohashi K; Kim SW; Ikegame K; Kanda Y; Kobayashi H; Ishikawa J; Ago H; Hirokawa M; Fukuda T; Atsuta Y; Kondo T
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1536-1543. PubMed ID: 30826464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matched unrelated transplants.
    Welte K
    Semin Oncol Nurs; 1994 Feb; 10(1):20-7. PubMed ID: 8165375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.